You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
The Arctic Front Cryoballoon Catheter family are the leading cryoballoon catheters approved in Europe to treat atrial fibrillation (AF). They have a low complication risk and a proven efficacy in treating AF.1
The Freezor™ family of cardiac cryoablation catheters are flexible, single-use, minimally invasive devices designed to ablate cardiac tissue. Used in conjunction with the CryoConsole, they are the only focal catheters that utilize the Cryo energy source, with ablation indications ranging from atrioventricular nodal reentry tachycardia (AVNRT) to atrial arrhythmias.
The CryoConsole houses the components and software needed to perform Cryoablation procedures with the Arctic Front Cardiac Cryoablation Catheter Family or the Freezor family of cardiac cryoablation catheters. It controls the delivery, recovery, and disposal of cryoablation refrigerant safely and efficiently.
The FlexCath Advance™ Steerable Sheath is part of the Arctic Front Cardiac Cryoablation Catheter Family and Arctic Front Advance Pro™ Cardiac Cryoablation Catheter System and is the only sheath that has been tested for use with the Arctic Front Advance Pro™ Cardiac Cryoablation Catheter. It can also be used with the Freezor™ family of Cardiac Cryoablation Catheters.
The Pulmonary Vein Ablation Catheter GOLD (PVAC™ GOLD) is designed to be used for the creation of endocardial lesions (focal and linear) during cardiac ablation procedures for the treatment of symptomatic atrial fibrillation (AF). The PVAC Gold is also intended to be used for cardiac electrophysiological (EP) mapping of pulmonary vein potentials, delivery of diagnostic pacing stimuli, and verifying electrical isolation of the pulmonary veins post-treatment.
Product names on this page are trademarks or registered trademarks of Medtronic.
Kuck KH,et al. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. NEJM April 2016. DOI: 10.1056/NEJM oa1602014
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.